PRESS RELEASES Amir Reichman 2/2/23 Amir Reichman 2/2/23 BiondVax Presenting at BIO CEO & Investor Conference Read More Amir Reichman 1/23/23 Amir Reichman 1/23/23 BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study Read More Amir Reichman 1/6/23 Amir Reichman 1/6/23 BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study Read More Amir Reichman 1/5/23 Amir Reichman 1/5/23 BiondVax to Present at Biotech Showcase 2023 Read More Newer Posts
Amir Reichman 2/2/23 Amir Reichman 2/2/23 BiondVax Presenting at BIO CEO & Investor Conference Read More
Amir Reichman 1/23/23 Amir Reichman 1/23/23 BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study Read More
Amir Reichman 1/6/23 Amir Reichman 1/6/23 BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study Read More
